Chong Kun Dang Bio (063160) Stock Outlook 2026: Fermentation APIs, Probiotics Ingredients and the Governance Overhang
Chong Kun Dang Bio (063160) 2026 stock outlook. A deep qualitative look at its fermentation-based active pharmaceutical ingredients, B2B probiotics raw-material franchise, CDMO growth optionality, plus the customer-concentration and Korean group-governance risks that keep the multiple in check.